chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Posture abnormal, Pyrexia, SARS-CoV-2 test positive, Somnolence, Urinary tract infection
Clinical narrative: The patient has a history of COPD, diabetes, multiple sclerosis, and CHF. On 2/15/23, she developed a fever and took an at-home COVID test which was positive. She had a virtual visit with her primary provider and was started on paxlovid. Later that evening, her daughter went to wake up the patient and noticed it was harder to wake the patient than it normally is. Her daughter also noted the patient was weak and slumping to her side, so she called EMS. In the ED, the patient also endorsed weakness, cough, headache, shortness of breath, and chest pain. A COVID PCR test also done in the ED resulted positive. She was admitted to the hospital 2/15/23 - 2/20/23. Of note, during her admission, she was also diagnosed and treated for a UTI. The patient has received the primary COVID vaccine series and three boosters.
Age: 21.0
Sex: F
Vaccine: UNK
Symptoms: Headache, Nausea, Tremor
Clinical narrative: HEADACHE, NAUSEA WITH NO RELIEF FROM ZOFRAN, SHAKY
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia, Pneumonia
Clinical narrative: Moderna vaccine was administered outside of facility- reported by patient ? NO LOT NUMBER WERE SUPPLIED ------------------------------------------------------------------------------------------------------------------------- J96.00 ACUTE RESPIRATORY FAILURE 12/9/2022 PNEUMONIA R09.02 HYPOXIA 12/9/2022 PNEUMONIA
Age: 43.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood test abnormal, Diabetes mellitus, Fatigue, Glycosylated haemoglobin abnormal, Malaise
Clinical narrative: In February 2023, I went for my annual well visit and we did some blood work.  The results were abnormal for thyroid and A1C.  I was having weight gain and fatigue and general unwell feeling.  I was diagnosed as diabetic.  Before the vaccine, my A1C and sugar levels had always been normal.  We had been keeping good track of my A1C for several months before this diagnosis.
Age: 43.0
Sex: F
Vaccine: COVID19-2
Symptoms: Thyroid function test abnormal, Weight increased
Clinical narrative: In February 2023, I went for my annual well visit and we did some blood work.  The results were abnormal for thyroid and A1C.  I was having weight gain and fatigue and general unwell feeling.  I was diagnosed as diabetic.  Before the vaccine, my A1C and sugar levels had always been normal.  We had been keeping good track of my A1C for several months before this diagnosis.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Adrenal gland cancer, Biopsy lung, Biopsy lung abnormal, Chemotherapy, Chest X-ray abnormal
Clinical narrative: I had been eating some pork rinds, I inhaled them that caused me to have a bad cough, I made an appointment with my doctor. He ordered a chest x-ray to make sure I had not gotten any debris left in my lungs and gotten bacterial pneumonia. The chest x-ray showed, something in my right lung, so he ordered a CAT scan. The CAT scan confirmed there was something in my right lung. My doctor ordered a needle biopsy, the needle biopsy was inconclusive. I was the scheduled for a surgical biopsy, the results came back showing adrenal carcinoma. I have started chemotherapy, that has made me very ill.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram abnormal, Cough, Lung disorder
Clinical narrative: I had been eating some pork rinds, I inhaled them that caused me to have a bad cough, I made an appointment with my doctor. He ordered a chest x-ray to make sure I had not gotten any debris left in my lungs and gotten bacterial pneumonia. The chest x-ray showed, something in my right lung, so he ordered a CAT scan. The CAT scan confirmed there was something in my right lung. My doctor ordered a needle biopsy, the needle biopsy was inconclusive. I was the scheduled for a surgical biopsy, the results came back showing adrenal carcinoma. I have started chemotherapy, that has made me very ill.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Hepatocellular carcinoma, Hypotension, Renal failure
Clinical narrative: I95.9 HYPOTENSION 9/14/2022 HEPATOCELLULAR CARCINOMA I95.9 HYPOTENSION 9/14/2022 RENAL FAILURE
Age: 1.0
Sex: F
Vaccine: HEPA
Symptoms: Expired product administered
Clinical narrative: VACCINE EXPIRED ON 4/28/23 AND WAS ADMINISTERED ON 5/2/23 BY CLINIC RN
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anaemia, Cerebral artery occlusion, Cerebrovascular accident, Delirium
Clinical narrative: ACUTE STROKE DUE TO OCCLUSION OF LEFT MIDDLE CEREBRAL ARTERY 11/22/2022 DELIRIUM DUE TO MULTIPLE ETIOLOGIES  ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/30/2022 DELIRIUM DUE TO MULTIPLE ETIOLOGIES  ACUTE STROKE DUE TO OCCLUSION OF LEFT MIDDLE CEREBRAL ARTERY 11/22/2022 ANEMIA  ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/30/2022 ANEMIA
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anaemia, Hypoxia, Metastases to lung, Metastases to lymph nodes
Clinical narrative: J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/8/2022 CANCER METASTATIC TO UNSPECIFIED LN J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 11/26/2022 CANCER METASTATIC TO UNSPECIFIED LN J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 11/25/2022 CANCER METASTATIC TO UNSPECIFIED LN R09.02 HYPOXIA 6/28/2022 CANCER METASTATIC TO UNSPECIFIED LN J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/8/2022 ANEMIA J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 11/26/2022 ANEMIA J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 11/25/2022 ANEMIA R09.02 HYPOXIA 6/28/2022 ANEMIA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/8/2022 THORACIC VERTEBRA PATHOLOGICAL FX DUE TO NEOPLASM, INIT J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 11/26/2022 THORACIC VERTEBRA PATHOLOGICAL FX DUE TO NEOPLASM, INIT J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 11/25/2022 THORACIC VERTEBRA PATHOLOGICAL FX DUE TO NEOPLASM, INIT R09.02 HYPOXIA 6/28/2022 THORACIC VERTEBRA PATHOLOGICAL FX DUE TO NEOPLASM, INIT J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/8/2022 CANCER METASTATIC TO UNSPECIFIED LUNG J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 11/26/2022 CANCER METASTATIC TO UNSPECIFIED LUNG J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 11/25/2022 CANCER METASTATIC TO UNSPECIFIED LUNG R09.02 HYPOXIA 6/28/2022 CANCER METASTATIC TO UNSPECIFIED LUNG
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Neoplasm, Neoplasm malignant, Respiratory failure, Thoracic vertebral fracture
Clinical narrative: J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/8/2022 CANCER METASTATIC TO UNSPECIFIED LN J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 11/26/2022 CANCER METASTATIC TO UNSPECIFIED LN J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 11/25/2022 CANCER METASTATIC TO UNSPECIFIED LN R09.02 HYPOXIA 6/28/2022 CANCER METASTATIC TO UNSPECIFIED LN J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/8/2022 ANEMIA J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 11/26/2022 ANEMIA J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 11/25/2022 ANEMIA R09.02 HYPOXIA 6/28/2022 ANEMIA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/8/2022 THORACIC VERTEBRA PATHOLOGICAL FX DUE TO NEOPLASM, INIT J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 11/26/2022 THORACIC VERTEBRA PATHOLOGICAL FX DUE TO NEOPLASM, INIT J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 11/25/2022 THORACIC VERTEBRA PATHOLOGICAL FX DUE TO NEOPLASM, INIT R09.02 HYPOXIA 6/28/2022 THORACIC VERTEBRA PATHOLOGICAL FX DUE TO NEOPLASM, INIT J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/8/2022 CANCER METASTATIC TO UNSPECIFIED LUNG J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 11/26/2022 CANCER METASTATIC TO UNSPECIFIED LUNG J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 11/25/2022 CANCER METASTATIC TO UNSPECIFIED LUNG R09.02 HYPOXIA 6/28/2022 CANCER METASTATIC TO UNSPECIFIED LUNG
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Dehydration, Hypothyroidism, Ischaemic stroke
Clinical narrative: I63.9 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 10/27/2022 DEHYDRATION J96.10 CHRONIC RESPIRATORY FAILURE 10/13/2022 DEHYDRATION I63.9 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 10/27/2022 SUBCLINICAL HYPOTHYROIDISM J96.10 CHRONIC RESPIRATORY FAILURE 10/13/2022 SUBCLINICAL HYPOTHYROIDISM
Age: 0.33
Sex: M
Vaccine: DTPPVHBHPB, PNC15, RV1, DTPPVHBHPB, PNC15, RV1
Symptoms: Infant irritability, Rash maculo-papular
Clinical narrative: Patient received vaccines ~ 20 hours later developed diffuse, macular rash with some papular areas. Afebrile but fussy.  inconsistent with topical clotrimazole reaction that was put on neck. Not consistent with viral exanthem. Treatment of Benadryl PRN.
Age: 0.33
Sex: M
Vaccine: DTPPVHBHPB, PNC15, RV1, DTPPVHBHPB, PNC15, RV1
Symptoms: Irritability, Rash macular, Rash papular
Clinical narrative: Patient received vaccines ~ 20 hours later developed diffuse, macular rash with some papular areas. Afebrile but fussy.  inconsistent with topical clotrimazole reaction that was put on neck. Not consistent with viral exanthem. Treatment of Benadryl PRN.
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Fatigue, Postural orthostatic tachycardia syndrome, Seizure
Clinical narrative: Pots, AE, seizures, fatigue
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Headache, Malaise
Clinical narrative: Didn?t feel good in general, had a headache and a stuffy nose.  In the afternoon I developed a fever peaking at 103.3.  Headache was very severe.  Slight cough.  3/28 Tested with At Home COVID-19 Test, Positive.  3/29 Televisit with Doctor.  Who proscribed Molnupiravir.  Fever lasted several days peaking at 102.  Lost most of sense of taste, only able to tase very sweet or very salty things.  On 4/1, the fever dropped to 100.9 or 100.6.   headache diminished as well, but fatigue lingered.  Nasal congestion led to coughing more than any other reason.  Went back to work on 4/3, and the symptoms were greatly reduced.  Taste returned after 2 weeks with fatigue lingered for about 3 weeks.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Pyrexia, SARS-CoV-2 test positive, Taste disorder
Clinical narrative: Didn?t feel good in general, had a headache and a stuffy nose.  In the afternoon I developed a fever peaking at 103.3.  Headache was very severe.  Slight cough.  3/28 Tested with At Home COVID-19 Test, Positive.  3/29 Televisit with Doctor.  Who proscribed Molnupiravir.  Fever lasted several days peaking at 102.  Lost most of sense of taste, only able to tase very sweet or very salty things.  On 4/1, the fever dropped to 100.9 or 100.6.   headache diminished as well, but fatigue lingered.  Nasal congestion led to coughing more than any other reason.  Went back to work on 4/3, and the symptoms were greatly reduced.  Taste returned after 2 weeks with fatigue lingered for about 3 weeks.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Cardiac failure congestive
Clinical narrative: J96.00 ACUTE RESPIRATORY FAILURE 12/21/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Dyspnoea, Hypoxia
Clinical narrative: HYPOXIA 11/12/2022 ATRIAL FIBRILLATION W RAPID VENTRICULAR RESPONSE  HYPOXIA 11/12/2022 SHORTNESS OF BREATH
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Obstructive sleep apnoea syndrome, Urethral stenosis
Clinical narrative: G47.33 ADULT OBSTRUCTIVE SLEEP APNEA, MILD 10/17/2022 ADULT OBSTRUCTIVE SLEEP APNEA, MILD J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/1/2022 ADULT OBSTRUCTIVE SLEEP APNEA, MILD G47.33 ADULT OBSTRUCTIVE SLEEP APNEA, MILD 10/17/2022 MALE BULBOUS URETHRAL STRICTURE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/1/2022 MALE BULBOUS URETHRAL STRICTURE
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Lung adenocarcinoma, Magnetic resonance imaging head abnormal
Clinical narrative: J96.00 ACUTE RESPIRATORY FAILURE 10/11/2022 ABNL HEAD MRI J96.00 ACUTE RESPIRATORY FAILURE 10/11/2022 ADENOCARCINOMA LUNG, UNSPECIFIED SITE
Age: 0.17
Sex: F
Vaccine: DTPPVHBHPB, PNC15, RV5, DTPPVHBHPB, PNC15, RV5
Symptoms: Crying, Hypophagia, Injection site pain, Pain, Rash
Clinical narrative: Mother and grandmother report that patient began crying shortly after her vaccines were given and continued crying even after they got home.  She had been given tylenol in the clinic with her vaccines.  Mother gave 80 mg of tylenol at 12:30 pm, and patient continued to cry.  Mother called the clinic at 1:45 and was instructed to bring baby back to the clinic.  Baby was crying intermittently when she arrived.   She had missed a feeding due to crying.  Warm compress with heel warmers were applied to both side which appears to provide some relief of pain.  Patient went to sleep until she was examined again.  Initial HR in clinic was 198.  Pt took 2 ounces of her bottle and went to sleep.  She was observed in clinic for some time.  She was given 50 mg of ibuprofen at 3:30 pm.  HR was improved to 126.  Patient was resting well.  Injection sites were without erythema or swelling.  They were both noted to be tender.  She developed some mild papular rash (heat rash) to her upper chest.  No urticaria.  Patient was discharged to her home with instructions to continue warm compresses for comfort and tylenol every 4-6 hours as needed for fever or pain.
Age: 0.17
Sex: F
Vaccine: DTPPVHBHPB, PNC15, RV5, DTPPVHBHPB, PNC15, RV5
Symptoms: Rash papular
Clinical narrative: Mother and grandmother report that patient began crying shortly after her vaccines were given and continued crying even after they got home.  She had been given tylenol in the clinic with her vaccines.  Mother gave 80 mg of tylenol at 12:30 pm, and patient continued to cry.  Mother called the clinic at 1:45 and was instructed to bring baby back to the clinic.  Baby was crying intermittently when she arrived.   She had missed a feeding due to crying.  Warm compress with heel warmers were applied to both side which appears to provide some relief of pain.  Patient went to sleep until she was examined again.  Initial HR in clinic was 198.  Pt took 2 ounces of her bottle and went to sleep.  She was observed in clinic for some time.  She was given 50 mg of ibuprofen at 3:30 pm.  HR was improved to 126.  Patient was resting well.  Injection sites were without erythema or swelling.  They were both noted to be tender.  She developed some mild papular rash (heat rash) to her upper chest.  No urticaria.  Patient was discharged to her home with instructions to continue warm compresses for comfort and tylenol every 4-6 hours as needed for fever or pain.
Age: 76.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Rash (on lower back and stomach), pain in the area of rash
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Cardiac disorder, Cardiac stress test abnormal, Chest discomfort, Dyspnoea
Clinical narrative: Although I had shortness of breath since my second or third shot on 11/128/21 and 7/12/22 I did not equate it to the vaccine. However it did interfere with my wok cleaning my property and generally grounds work and cleaning. I just thought I was getting old.  On March 15, 2023 I was moving snow after a severe storm the day before when I got a sudden tightening in my chest. I stopped immediately and went in side. The very next day was my yearly physical. They did an EKG after I told them what had happened and there was signs of minor damage. They ordered a stress test and when I started the test on. a incline machine, within five minutes my blood pressure shot so high they said we had to stop the stress test so an to not have me "stroke out". I was unfamiliar with the term but got the gist of it and stopped and lay down.  Since that time I have been prescribed Losartan (50 ml) and the chest pain is almost gone but after Physical therapy my bp shoots up after exercise like it did on the treadmill. My shortness of breath persists.  I never took pharmaceuticals and prided myself on having a healthy lifestye and eating habits. I wore a mask throughout Covid until April of this year.  Tested for covid before visiting family and generrally have been healthy although about 15 pounds overweight (175) up from my long standing 160lbs. since 50.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram abnormal
Clinical narrative: Although I had shortness of breath since my second or third shot on 11/128/21 and 7/12/22 I did not equate it to the vaccine. However it did interfere with my wok cleaning my property and generally grounds work and cleaning. I just thought I was getting old.  On March 15, 2023 I was moving snow after a severe storm the day before when I got a sudden tightening in my chest. I stopped immediately and went in side. The very next day was my yearly physical. They did an EKG after I told them what had happened and there was signs of minor damage. They ordered a stress test and when I started the test on. a incline machine, within five minutes my blood pressure shot so high they said we had to stop the stress test so an to not have me "stroke out". I was unfamiliar with the term but got the gist of it and stopped and lay down.  Since that time I have been prescribed Losartan (50 ml) and the chest pain is almost gone but after Physical therapy my bp shoots up after exercise like it did on the treadmill. My shortness of breath persists.  I never took pharmaceuticals and prided myself on having a healthy lifestye and eating habits. I wore a mask throughout Covid until April of this year.  Tested for covid before visiting family and generrally have been healthy although about 15 pounds overweight (175) up from my long standing 160lbs. since 50.
Age: 18.0
Sex: F
Vaccine: MMRV
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: no symptoms, patient was notified and was okay with everything and was very understanding
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Anal cancer, Chronic respiratory failure, Hyponatraemia, Hypotension, Hypoxia
Clinical narrative: HYPOTENSION 8/24/2022 HYPONATREMIA  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 11/3/2022 HYPONATREMIA  HYPOXIA 8/30/2022 HYPONATREMIA  HYPOTENSION 8/24/2022 CANCER METASTATIC TO LIVER  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 11/3/2022 CANCER METASTATIC TO LIVER  HYPOXIA 8/30/2022 CANCER METASTATIC TO LIVER  HYPOTENSION 8/24/2022 ANAL CANCER, UNSPECIFIED SITE  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 11/3/2022 ANAL CANCER, UNSPECIFIED SITE  HYPOXIA 8/30/2022 ANAL CANCER, UNSPECIFIED SITE  HYPOTENSION 8/24/2022 ANAL CANCER, UNSPECIFIED SITE  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 11/3/2022 ANAL CANCER, UNSPECIFIED SITE  HYPOXIA 8/30/2022 ANAL CANCER, UNSPECIFIED SITE
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Metastases to liver, Neoplasm malignant, Respiratory failure
Clinical narrative: HYPOTENSION 8/24/2022 HYPONATREMIA  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 11/3/2022 HYPONATREMIA  HYPOXIA 8/30/2022 HYPONATREMIA  HYPOTENSION 8/24/2022 CANCER METASTATIC TO LIVER  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 11/3/2022 CANCER METASTATIC TO LIVER  HYPOXIA 8/30/2022 CANCER METASTATIC TO LIVER  HYPOTENSION 8/24/2022 ANAL CANCER, UNSPECIFIED SITE  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 11/3/2022 ANAL CANCER, UNSPECIFIED SITE  HYPOXIA 8/30/2022 ANAL CANCER, UNSPECIFIED SITE  HYPOTENSION 8/24/2022 ANAL CANCER, UNSPECIFIED SITE  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 11/3/2022 ANAL CANCER, UNSPECIFIED SITE  HYPOXIA 8/30/2022 ANAL CANCER, UNSPECIFIED SITE
Age: 68.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster
Clinical narrative: Patient adamant that the shot caused a severe case of shingles on her back.
Age: 68.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Blister, Herpes zoster, Injection site pain, Pain, Pruritus
Clinical narrative: Patient adamant that the shot caused a severe case of shingles on her back.
Age: 68.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Vaccine positive rechallenge
Clinical narrative: Patient adamant that the shot caused a severe case of shingles on her back.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: no adverse side effects noted.
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Fatigue, General physical health deterioration, Malaise, Mobility decreased, Pyrexia
Clinical narrative: The night of getting the shot I woke up in the night and I a fever of 100.5 degrees which lasted for about a week. I was very fatigued as well. I spent that week in bed and was just unwell. I had had the fatigue last up to this day. There has been a downturn in my general health since having had the vaccine.
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Sleep disorder
Clinical narrative: The night of getting the shot I woke up in the night and I a fever of 100.5 degrees which lasted for about a week. I was very fatigued as well. I spent that week in bed and was just unwell. I had had the fatigue last up to this day. There has been a downturn in my general health since having had the vaccine.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, VARCEL
Symptoms: Cellulitis, Erythema, Rash papular, Skin warm
Clinical narrative: MOP reports raised with patch like marks that is hot to touch , as well as red. Diagnosed with cellulitis. Pt was prescribed with cephalexin QID for 7 days.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Central venous catheterisation, Fatigue, Haemoptysis, Pneumonia
Clinical narrative: In January 2023, I was feeling very tired and when I laid down, I felt blood. I coughed up clots of blood. I laid back down and the next morning I saw the doctor. I was referred to an infectious disease doctor. I had pneumonia. My antibiotic was changed at this time. I began intervenes antibiotics immediately. I got the PIC line put in at the emergency department. I had visiting nurses come to the house to administer needed medications. I took this medication from 01/14/2023 through 01/28/2023. After they took the PIC line out I still felt very weak. It took several more weeks to feel better.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Sputum culture, Thrombosis
Clinical narrative: In January 2023, I was feeling very tired and when I laid down, I felt blood. I coughed up clots of blood. I laid back down and the next morning I saw the doctor. I was referred to an infectious disease doctor. I had pneumonia. My antibiotic was changed at this time. I began intervenes antibiotics immediately. I got the PIC line put in at the emergency department. I had visiting nurses come to the house to administer needed medications. I took this medication from 01/14/2023 through 01/28/2023. After they took the PIC line out I still felt very weak. It took several more weeks to feel better.
Age: 17.0
Sex: M
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: In error, I administered Pfizer Bivalent vaccine for 5-11 year old to a 17 year old. It is the patients first bivalent vaccine. No reaction or symptoms after administration.
Age: 54.0
Sex: F
Vaccine: COVID19-2
Symptoms: Fatigue, Hypersomnia, Pain
Clinical narrative: Woke up the next morning in severe pain - 10/10.  Took acetaminohen, 1000mg, PO without relief.  It felt like every injury I had ever had in my life was back and at full pain level.  Being retired - that was A LOT of pain from my head to my toes!  I used heat and alternated tylenol, ibuprofen, and aspirin throughout the day to try to find relief. By the end of the day I was exhausted and the pain and finally decreased.  I remember sleeping between 10 and 14 hours each night for the next 3 nights,  No one should have to take this vaccine and I am a Nurse.  I have to recommend this to others, even though it did this to me.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Pyrexia
Clinical narrative: patient had a low grade fever and  aches. taking tylenol
Age: 80.0
Sex: M
Vaccine: COVID19-2, UNK
Symptoms: COVID-19, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: I was having a runny nose and a fever. I then took a COVID-19 Home Test and it was positive I then called my healthcare provider, and they got me on Paxlovid. On May 3rd I was still positive but by the 6th it was negative.
Age: 0.33
Sex: M
Vaccine: HIBV, UNK
Symptoms: Product preparation error
Clinical narrative: No additional AEs; PEDVAX HIB was diluted with Merck Sterile Diluent and administered to a 4 month old; This spontaneous report was received from an medical assistant and refers to a 4-month-old male patient. The patient had none pre-existing physician-diagnosed allergies, birth defects, medical conditions. The patient had none illness at time of vaccination. Concomitant vaccinations administered on the same day included diphtheria vaccine toxoid (+) hepatitis b vaccine rhbsag (yeast) (+) pertussis vaccine acellular 3-component (+) polio vaccine inact 3v (vero) (+) tetanus vaccine toxoid (PEDIARIX), pneumococcal vaccine conj 13v (crm197) (PREVNAR 13) and rotavirus vaccine live oral 1v (ROTARIX).  On 18-APR-2023, the patient was vaccinated with second dose haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, lot #W006596, expiration date: 11-OCT-2024, administered intramuscularly in right vastus lateralis, for prophylaxis (exact dose was not provided), with 0.5 ml sterile diluent (MERCK STERILE DILUENT) solution for injection/infusion, lot #W014210, expiration date: 27-NOV-2024, administered intramuscularly, added to the vaccine (Product preparation error). The vaccine did not required dilution. The vaccine provider did not realize that was incorrect until after administration. The vaccine provider promptly reported error to physician and supervisor for further instructions. The physician notified parent. The vaccine was administered at public health clinic. No additional adverse events (AEs) was reported. There was no temperature excursion.
Sex: U
Vaccine: HPV9
Symptoms: Expired product administered, No adverse event
Clinical narrative: HCP called too report that expired dose of GARDASIL 9 ( EXP: 04-SEP-2022 ) was given; No additional AE/PQC.; This spontaneous report was received from a healthcare professional and refers to a patient of unknown age and gender. There was no information about patient's concomitant medications, concurrent conditions or pertinent medical history.  On an unknown date, the patient was vaccinated with an expired dose (expired product administered) of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9), 0.5 mL, with expiration date 04-SEP-2022 (route, anatomical location, and lot number were not reported) for prophylaxis. No additional adverse events were reported.
Sex: U
Vaccine: HPV9
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; Call transferred from MNSC. Nurse calling to report adverse event on expired dose of GARDASIL 9 was accidentally administered to a patient. Permission to contact HCP was unspecified. No other information provided. No additional AE/PQC reported.; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 11-JAN-2023, the patient was accidentally vaccinated with an expired dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) prefilled syringe, 1 dose, lot #T025367, administered for prophylaxis (strength, and route of administration were not provided). The vaccine expired on 18-NOV-2022.  No adverse events were reported.
Sex: U
Vaccine: HEPA
Symptoms: Product storage error
Clinical narrative: no adverse event; the patient was given a dose of VAQTA after the dose was stored improperly; This spontaneous report was received from other health professional and refers to a patient of unspecified age and gender. There was no information regarding the patient's medical history, concurrent condition or concomitant therapies details.  On 02-MAY-2023, vaccine hepatitis A vaccine, inactivated (VAQTA) lot #X003791, expiry date 01-JUN-2024 was involved into temperature excursion of 34 Fahrenheit degrees for 7 hours and on the same day, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 0.5ml series, lot #X003791, expiration date: 01-JUN-2024, administered for prophylaxis (strength, and route of administration were not provided) (Product storage error).
Sex: U
Vaccine: PNC15
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE; patient was given a dose of VAXNEUVANCE after the dose was stored improperly; This spontaneous report was received from a Medical Assistant and referred to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions and allergies were not reported.   On 02-MAY-2023, pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE), 0.5 milliliter injection, 0.5 milliliter, lot #W027275, expiration date: 09-JUL-2024, was underwent a temperature excursion of 34 degree Fahrenheit (F) for 7 hours. No previous temperature excursion.   On 03-MAY-2023, the improperly stored vaccines was administered to patient for prophylaxis (route of administration was not provided) (product storage error). No additional adverse events (AEs).
Age: 4.0
Sex: M
Vaccine: HEPA
Symptoms: Extra dose administered, Inappropriate schedule of product administration, No adverse event
Clinical narrative: No Additional AE; patient who has been vaccinated with 2 doses of VAQTA received his 3rd dose of VAQTA too early and was not; patient who has been vaccinated with 2 doses of VAQTA received his 3rd dose of VAQTA too early and was not; This spontaneous report was received from a medical assistant referring to 4-year-old male patient. Information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions/ allergies was not provided.  On 09-MAY-2023, the patient was vaccinated with thrid dose of hepatitis A vaccine, inactivated (VAQTA) intramuscular injection (0.5 mL, lot #X001293 was considered as valid for formulation vial, expiration date 21-JUN-2024, route of administration and anatomical location were not provided) for immunization. That dose was administered too early and was not supposted to be given (Inappropriate schedule of vaccine administered, Extra dose administered). No additional adverse event (AE). No product quality complaint (PQC).
Sex: F
Vaccine: HPV4, HPV9
Symptoms: Interchange of vaccine products
Clinical narrative: no adverse event; patient's initial series was started with the 4-valent GARDASIL (GARDASIL dose 1 on 09/05/2014 and GARDASIL dose 2 on 11/5/2014) then her third dose was with GARDASIL 9 (GARDASIL 9 on 11/27/2017) / received her fourth dose with GARDASIL 9  4/17/2023; This spontaneous report was received from a nurse prescriber and refers to a 18 year old female patient. No information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions or allergies was provided.  It was reported that the patient's initial series was started with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL), dose 1 on 05-SEP-2014, for prophylaxis (dose, route of administration, lot/batch # and expiration date were not reported), and quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) dose 2 on 05-NOV-2014, for prophylaxis (dose, route of administration, lot/batch # and expiration date were not reported).  Then her third dose was with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) on 27-NOV-2017 (interchange of vaccine products) for prophylaxis (dose, route of administration, lot/batch # and expiration date were not reported) which the nurse prescriber referred was intended to be the patient's last dose. However, the patient then received her fourth dose with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) on 17-APR-2023, lot# W008445 with expiration date of 09-NOV-2024, 0.5ml, for prophylaxis (route of administration was not reported).   No other event reported. No further clarify.
Age: 16.0
Sex: M
Vaccine: COVID19-2
Symptoms: Extra dose administered
Clinical narrative: Pt here for a wellness exam. Per clinic records patient was due for covid # 3 bivalent dose. Called mom to obtain verbal consent, mom did not disclosed of any booster given prior. After reviewing state records it appeared that patient had already obtained the covid bivalent dose. Inform mom of extra dose of the covid bivalent given to patient. Mom understood and was okay with the situation as she rather have patient be extra protected. Advised mom to observe patient for any adverse reaction. Mom understood.  Patient was observed in clinic for more than 30 minutes.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Cardiac ablation, Cardioversion, Haemoglobin decreased, Parkinson's disease
Clinical narrative: Hemoglobin dropped from 14 to 5.7 and I needed 3 units of blood.  After this event, I then had a fib and needed Cardo version and then ablation.  After all that, I was diagnosed with Parkinson?s.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Transfusion
Clinical narrative: Hemoglobin dropped from 14 to 5.7 and I needed 3 units of blood.  After this event, I then had a fib and needed Cardo version and then ablation.  After all that, I was diagnosed with Parkinson?s.
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Fatigue, Hypersomnia, Impaired work ability
Clinical narrative: I had a cough. I went to an urgent care, and I was given a cough medicine, which I took for one day before my cough went away. I was a little tired, so I slept the first day. My symptoms were mild, and I didn't feel bad, but I had to stay at home and self-isolate for five days before I could return to work. I just hung around the house. I was fully recovered by the third or fourth day.
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Malaise, SARS-CoV-2 test positive
Clinical narrative: I had a cough. I went to an urgent care, and I was given a cough medicine, which I took for one day before my cough went away. I was a little tired, so I slept the first day. My symptoms were mild, and I didn't feel bad, but I had to stay at home and self-isolate for five days before I could return to work. I just hung around the house. I was fully recovered by the third or fourth day.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash vesicular
Clinical narrative: A couple of days after injection a rash appeared on my right side.  Mostly on me back, but a little wrapping around on the left side onto the chest. Televisit with doctor who recommended a cream and a new soap to wash with.  The rash was very painful and had blisters. It spread over the course of a month. The blisters on my chest developed as far as between my breasts.   Once the blisters disappeared, I got relief.  No medicines or creams had any effect.  About a month later, I sought care from an acupuncturist and the rash disappeared after that session.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Extra dose administered
Clinical narrative: Immunization given on 02/10/2023 at pharmacy when reviewing pt shot record for 2nd dose follow up. Dr office reported to clinic on 2/14/2023 they had administered Shingrix shot to pt on 02/05/2023
Age: 1.5
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Erythema, Local reaction, Skin warm
Clinical narrative: Large local reaction, hot to the touch, 4 inches in diameter, red mark with ring around center mark, persisting for over 16 days.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Coagulation test normal, Eczema, Fatigue, Headache
Clinical narrative: After shot #2 I became physically ill for 7 days - headache, severe body aches, chills, extreme fatigue.  Two weeks after receiving shot #2 I developed severe eczema that became worse over the weeks until it covered both hands and wrists, this eczema (which I never had before) lasted ten months, confirmed by two dermatologists.  Twenty months later, I developed a sudden vascular retinal occlusion of my left eye.  I do not have hypertension, diabetes, high cholesterol, never smoked, and had a complete coagulopathy workup ordered, all was normal.  I am now receiving intravitreal injections, for the rest of my life.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Impaired work ability, Malaise, Pain, Retinal vascular occlusion
Clinical narrative: After shot #2 I became physically ill for 7 days - headache, severe body aches, chills, extreme fatigue.  Two weeks after receiving shot #2 I developed severe eczema that became worse over the weeks until it covered both hands and wrists, this eczema (which I never had before) lasted ten months, confirmed by two dermatologists.  Twenty months later, I developed a sudden vascular retinal occlusion of my left eye.  I do not have hypertension, diabetes, high cholesterol, never smoked, and had a complete coagulopathy workup ordered, all was normal.  I am now receiving intravitreal injections, for the rest of my life.
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Erythema, Fatigue, Pain, Pain in extremity, Peripheral swelling
Clinical narrative: Injection given 5/15/2023, left arm pain & swelling 5/16/23 am, body aches, fatigue, left arm pink raised erythema 10cm X 14cm. Ice applied taking Motrin,
Age: 42.0
Sex: M
Vaccine: MMR
Symptoms: Expired product administered
Clinical narrative: The M-M-R II was expired. Patient was contacted and wants to come in in 4 weeks for revaccination. No reported reactions.
Age: 71.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Pain
Clinical narrative: Debilitating; All over body pain; muscular pain; This non-serious case was reported by a consumer via call center representative and described the occurrence of general body pain in a 71-year-old female patient who received Herpes zoster (Shingrix) (batch number 577BF, expiry date 30-SEP-2023) for prophylaxis.   Concurrent medical conditions included blood pressure high, diabetes and osteoarthritis.   On 03-APR-2023, the patient received the 1st dose of Shingrix (left arm). On 03-APR-2023, immediately after receiving Shingrix, the patient experienced general body pain (Verbatim: All over body pain). In APR-2023, the patient experienced muscle pain (Verbatim: muscular pain). On an unknown date, the patient experienced debility (Verbatim: Debilitating). The outcome of the general body pain and muscle pain were not resolved and the outcome of the debility was not reported.   It was unknown if the reporter considered the general body pain, debility and muscle pain to be related to Shingrix.     It was unknown if the company considered the general body pain, debility and muscle pain to be related to Shingrix.   Additional Information: GSK Receipt Date: 11-MAY-2023 The patient self-reported the case. The patient stated that she got the Shingrix vaccine at the beginning of April and immediately following the vaccine, she started to experience pain all over her body.  She stated that the pain was still present and debilitating. The patient did not get any definitive information of why she had the side effect of pain. The patient was going through 6th week of muscular pain. The patient stated that the company did not advertise six weeks pain and only advertise two to three days and stated that she would have not gotten the vaccine if she knew it would be this bad, she was not getting the second vaccine. The reporter consented to follow up.
Age: 71.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Asthenia, Myalgia, Pain
Clinical narrative: Debilitating; All over body pain; muscular pain; This non-serious case was reported by a consumer via call center representative and described the occurrence of general body pain in a 71-year-old female patient who received Herpes zoster (Shingrix) (batch number 577BF, expiry date 30-SEP-2023) for prophylaxis.   Concurrent medical conditions included blood pressure high, diabetes and osteoarthritis.   On 03-APR-2023, the patient received the 1st dose of Shingrix (left arm). On 03-APR-2023, immediately after receiving Shingrix, the patient experienced general body pain (Verbatim: All over body pain). In APR-2023, the patient experienced muscle pain (Verbatim: muscular pain). On an unknown date, the patient experienced debility (Verbatim: Debilitating). The outcome of the general body pain and muscle pain were not resolved and the outcome of the debility was not reported.   It was unknown if the reporter considered the general body pain, debility and muscle pain to be related to Shingrix.     It was unknown if the company considered the general body pain, debility and muscle pain to be related to Shingrix.   Additional Information: GSK Receipt Date: 11-MAY-2023 The patient self-reported the case. The patient stated that she got the Shingrix vaccine at the beginning of April and immediately following the vaccine, she started to experience pain all over her body.  She stated that the pain was still present and debilitating. The patient did not get any definitive information of why she had the side effect of pain. The patient was going through 6th week of muscular pain. The patient stated that the company did not advertise six weeks pain and only advertise two to three days and stated that she would have not gotten the vaccine if she knew it would be this bad, she was not getting the second vaccine. The reporter consented to follow up.
Age: 72.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Blood test normal, Burning sensation, Dermatitis allergic, Hypersensitivity, Pruritus
Clinical narrative: 4 or 5 days after receiving the 1st shingrix injection I broke out in a rash over approximately 70 % of my body. The rash was slightly itchy but was a burning sensation. Now, May 18th, I still have the rash. It still burns but appears a bit less threatening. Painful spots have shifted in location over the past 6 weeks. Received oral prednisone 40mg 5 days, then methyl-prednisone injection. The prednisone had little effect on the rash but side effects were poorly tolerated.
Age: 72.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Rash, Rash maculo-papular
Clinical narrative: 4 or 5 days after receiving the 1st shingrix injection I broke out in a rash over approximately 70 % of my body. The rash was slightly itchy but was a burning sensation. Now, May 18th, I still have the rash. It still burns but appears a bit less threatening. Painful spots have shifted in location over the past 6 weeks. Received oral prednisone 40mg 5 days, then methyl-prednisone injection. The prednisone had little effect on the rash but side effects were poorly tolerated.
Age: 72.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Blood test normal, Burning sensation, Rash, Rash pruritic
Clinical narrative: 4 or 5 days after receiving the 1st shingrix injection I broke out in a rash over approximately 70 % of my body. The rash was slightly itchy but was a burning sensation. Now, May 18th, I still have the rash. It still burns but appears a bit less threatening. Painful spots have shifted in location over the past 6 weeks. Received oral prednisone 40mg 5 days, then methyl-prednisone injection. The prednisone had little effect on the rash but side effects were poorly tolerated.
Age: 50.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Fatigue, Headache, Pruritus, Pruritus genital
Clinical narrative: Breakout rash; This non-serious case was reported by a consumer and described the occurrence of rash in a 50-year-old male patient who received Herpes zoster (Shingrix) (batch number YC5Y7, expiry date 25-OCT-2024) for prophylaxis.   The patient's past medical history included lymphoma (non-hodgkin's) (treated for Non-Hodgkin's Lymphoma in 2020). Concurrent medical conditions included anxiety, hypertension and multiple allergies. Concomitant products included losartan, sertraline hydrochloride (Zoloft), buspirone and cetirizine hydrochloride (Zyrtec).   On 01-MAY-2023, the patient received the 2nd dose of Shingrix. On 02-MAY-2023, 1 days after receiving Shingrix, the patient experienced rash (Verbatim: Breakout rash). The patient was treated with prednisone and hydroxyzine hydrochloride (Hydroxizine). The outcome of the rash was not resolved.   It was unknown if the reporter considered the rash to be related to Shingrix.     It was unknown if the company considered the rash to be related to Shingrix.   Additional Information: GSK Receipt Date: 09-MAY-2023 The patient received 2nd dose and experienced severe breakout rash. The patient received Prednisone and Hydroxizine on Sunday to fight rash. The patient had concomitant Losartan, Zoloft, Buspirone, Zyrtec and all are ongoing. On 2020 the patient was treated for Non-Hodgkin lymphoma. The reporter was requested for consent to follow up.
Age: 50.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Rash
Clinical narrative: Breakout rash; This non-serious case was reported by a consumer and described the occurrence of rash in a 50-year-old male patient who received Herpes zoster (Shingrix) (batch number YC5Y7, expiry date 25-OCT-2024) for prophylaxis.   The patient's past medical history included lymphoma (non-hodgkin's) (treated for Non-Hodgkin's Lymphoma in 2020). Concurrent medical conditions included anxiety, hypertension and multiple allergies. Concomitant products included losartan, sertraline hydrochloride (Zoloft), buspirone and cetirizine hydrochloride (Zyrtec).   On 01-MAY-2023, the patient received the 2nd dose of Shingrix. On 02-MAY-2023, 1 days after receiving Shingrix, the patient experienced rash (Verbatim: Breakout rash). The patient was treated with prednisone and hydroxyzine hydrochloride (Hydroxizine). The outcome of the rash was not resolved.   It was unknown if the reporter considered the rash to be related to Shingrix.     It was unknown if the company considered the rash to be related to Shingrix.   Additional Information: GSK Receipt Date: 09-MAY-2023 The patient received 2nd dose and experienced severe breakout rash. The patient received Prednisone and Hydroxizine on Sunday to fight rash. The patient had concomitant Losartan, Zoloft, Buspirone, Zyrtec and all are ongoing. On 2020 the patient was treated for Non-Hodgkin lymphoma. The reporter was requested for consent to follow up.
Age: 57.0
Sex: M
Vaccine: VARZOS, PNC20, VARZOS
Symptoms: Rash, Rash vesicular
Clinical narrative: 1 Day through Day 5 after Shingrix shot - muscle spasms in lower back muscles that lasted 5 days - had to take a muscle relaxant and wear a back brace to help move around (walk, get up, sit, lay down) -Day 2  through Day 4 after shot - Fever and chills -Day 5 through Day 13 (current day)  after shot - outbreak of chickenpox sores in mid torso, ankles, and a few spots on back, legs, and arms.   -Day 10 after shot -  sent doctor pictures of dots asking if a side affect of Shingrix vaccine---he confirmed it looked like Chickenpox but had never heard of such a reaching to a shingles vaccine.  No treatment--advised not to go out around unvaccinated people or anyone pregnant. NOTE:  The spots were red with white tips, look exactly like chicken pox sores, itched a lot at first, and only appeared in large numbers around mid-torso and ankles with just a few random spots anywhere else. -Day 13 after shot - spots not as bright red, but appear to be slowly fading in color, with less and less of them itching--Presume have to let run its course for another week after review with doctor -Patient remaining at home away from crowds